These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1313398)

  • 21. [Immunological effects of silica/asbestos].
    Kumagai N; Nishimura Y; Maeda M; Hayashi H; Otsuki T
    Nihon Eiseigaku Zasshi; 2010 Sep; 65(4):493-9. PubMed ID: 20885075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Asbestos-related cancer risk in patients with asbestosis or pleural plaques.
    Ameille J; Brochard P; Letourneux M; Paris C; Pairon JC
    Rev Mal Respir; 2011 Jun; 28(6):e11-7. PubMed ID: 21742228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physical activity in people with asbestos related pleural disease and dust-related interstitial lung disease: An observational study.
    Dale MT; McKeough ZJ; Munoz PA; Corte P; Bye PT; Alison JA
    Chron Respir Dis; 2015 Nov; 12(4):291-8. PubMed ID: 26048393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 24 years of pneumoconiosis mortality surveillance in Australia.
    Smith DR; Leggat PA
    J Occup Health; 2006 Sep; 48(5):309-13. PubMed ID: 17053296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiographic readings for asbestosis: misuse of science--validation of the ILO classification.
    Miller A
    Am J Ind Med; 2007 Jan; 50(1):63-7. PubMed ID: 17154406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Silica and asbestos: contrasts in tissue response.
    Heppleston AG
    Ann N Y Acad Sci; 1979; 330():725-44. PubMed ID: 230775
    [No Abstract]   [Full Text] [Related]  

  • 27. Osteopontin levels in an asbestos-exposed population.
    Park EK; Thomas PS; Johnson AR; Yates DH
    Clin Cancer Res; 2009 Feb; 15(4):1362-6. PubMed ID: 19174489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. k-ras mutation and occupational asbestos exposure in lung adenocarcinoma: asbestos-related cancer without asbestosis.
    Nelson HH; Christiani DC; Wiencke JK; Mark EJ; Wain JC; Kelsey KT
    Cancer Res; 1999 Sep; 59(18):4570-3. PubMed ID: 10493509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathology and pathophysiology of pneumoconiosis.
    Fujimura N
    Curr Opin Pulm Med; 2000 Mar; 6(2):140-4. PubMed ID: 10741774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between increased small airway obstruction and asbestos exposure in patients with asbestosis.
    Yang X; Yan Y; Xue C; Du X; Ye Q
    Clin Respir J; 2018 Apr; 12(4):1676-1684. PubMed ID: 29087047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysregulation of the immune system caused by silica and asbestos.
    Maeda M; Nishimura Y; Kumagai N; Hayashi H; Hatayama T; Katoh M; Miyahara N; Yamamoto S; Hirastuka J; Otsuki T
    J Immunotoxicol; 2010; 7(4):268-78. PubMed ID: 20849352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mortality in cases of asbestosis diagnosed by a pneumoconiosis medical panel.
    Coutts II; Gilson JC; Kerr IH; Parkes WR; Turner-Warwick M
    Thorax; 1987 Feb; 42(2):111-6. PubMed ID: 3433233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pleural effusion cytology of asbestos-associated malignant mesothelioma and lung carcinoma in the diagnosis of occupational diseases by the statutory accident insurance funds].
    Biesterfeld S; Schramm M; Schad A; Pomjanski N
    Pneumologie; 2014 Apr; 68(4):270-6. PubMed ID: 24615665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations, tissue accumulations, and serum levels of p53 in patients with occupational cancers from asbestos and silica exposure.
    Husgafvel-Pursiainen K; Kannio A; Oksa P; Suitiala T; Koskinen H; Partanen R; Hemminki K; Smith S; Rosenstock-Leibu R; Brandt-Rauf PW
    Environ Mol Mutagen; 1997; 30(2):224-30. PubMed ID: 9329647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological effects: asbestos-cement manufacturing.
    Weill H
    Ann Occup Hyg; 1994 Aug; 38(4):533-8, 413. PubMed ID: 7978975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apportionment in asbestos-related disease for purposes of compensation.
    Guidotti TL
    Ind Health; 2002 Oct; 40(4):295-311. PubMed ID: 12502232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and pathological aspects of lung cancer associated with asbestosis and other pneumoconiosis.
    Yokoyama K; Morinaga K; Yamamoto S; Sera Y
    J UOEH; 1983 Mar; 5 Suppl():75-82. PubMed ID: 6679676
    [No Abstract]   [Full Text] [Related]  

  • 38. Cancer mortality in a surveillance cohort of German males formerly exposed to asbestos.
    Pesch B; Taeger D; Johnen G; Gross IM; Weber DG; Gube M; Müller-Lux A; Heinze E; Wiethege T; Neumann V; Tannapfel A; Raithel HJ; Brüning T; Kraus T
    Int J Hyg Environ Health; 2010 Jan; 213(1):44-51. PubMed ID: 19783208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of radiographic asbestosis and the risk of lung cancer among asbestos-cement workers: Extended follow-up of a cohort.
    Finkelstein MM
    Am J Ind Med; 2010 Nov; 53(11):1065-9. PubMed ID: 20672325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibre content of lung in amphibole- and chrysotile-induced mesothelioma: implications for environmental exposure.
    Churg A; Wright JL
    IARC Sci Publ; 1989; (90):314-8. PubMed ID: 2545611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.